AKT1 and colorectal cancer: It is reported that the expression level in colorectal cancer is correlated with tumor sensitivity to chemotherapy and that NPM1 inhibition suppresses colorectal cancer progression by activating p53 and inhibiting protein kinase B (AKT) [10].